2 min read
RAPS US Convergence
Meet Veristat at RAPS US Convergence 2025
Where Regulatory Excellence Meets Real-World Impact
Veristat is delighted...
1 min read
Meet Veristat in Madrid at ESMO Congress 2023 , 20-24 October 2023
With nearly 30 years of experience in clinical trial planning and execution for cancer therapies, Veristat is equipped to support any development program.
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
As a versatile CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel cancer therapies. In the past five years, Veristat has supported more than 300 oncology studies and have worked on more than 30 US and European regulatory marketing applications for cancer treatments.
Poster Presentation
Don´t miss the presentation on Results from a Phase 2 pancreatic cancer study
Date of poster presentation: Monday, 23 October 2023
Location: Hall 8
Poster number: FPN# 1625P
Presented by: Thomas M Enzler, MD, PhD
Schedule A Meeting
Veristat team member, Balma Gil, Business Development Director, will be at the venue, ready to listen to your needs and share Veristat’s expertise.
If you would like to meet with us at ESMO Congress 2023, please contact us to arrange a meeting through the form.
We are…Bold. Scientific. Versatile. Veristat.
Conference Details
Website: ESMO Congress 2023
